(Total Views: 773)
Posted On: 05/30/2022 8:19:39 PM
Post# of 148878
Re: chuckles759 #123966
***My Opinion***
Medicine today is in a process of transition away from drugs that hide the festering illness which only lead unto a slower degeneration & inevitable death to drugs which eliminate or incapacitate illness leading unto regeneration & life.
It is becoming exceedingly obvious that LL has exactly what it takes to reduce cancer to only a diagnosis, to reduce HIV to a diagnosis. To possibly eliiminate NASH, just wait. (Wait for NAS to go to 0. Watch.) The extra ordinary powers this molecule possesses in its inordinate capacity & manner in which it binds to CCR5 will make it the lead drug in this revolutionary transitory process of conquering disease. This molecule will lead the charge and this company will orchestrate that revolution.
Although Leronlimab can stand alone in monotherapy, CytoDyn will take advantage of its friendly, harmonious nature and use it extensively in combination therapy since LL has no drug-drug interactions & no ASEs. CytoDyn shall become a conglomerate of symbiotic partnerships against a myriad of the worlds ailments, to make this revolution complete. BP will have no choice but to partner. Across the board, LL pan-partners with drugs that require its assistance to make it appear that they are actually functioning.
Later, once the Branded combination drug patent expires and it goes generic, the world will then realize that LL stand alone would of had the same beneficial effect. Regardless, given CytoDyn's current situation, this is how the revolutionary medicine transformation will be achieved.
Is there any wonder why Big Pharma wants this inevitable transition away from their expensive bandaids which only hide disease, permitting it to fester and demoralize towards meds like LL which eliminate and disable disease, which permit regeneration and life. Without the return of disease, there is no repeat income.
Ahead of us, It's an uphill battle, but day by day, we take a few steps higher. Some days we will go up by elevator.
CytoDynasty!
Should be an exciting month.
Medicine today is in a process of transition away from drugs that hide the festering illness which only lead unto a slower degeneration & inevitable death to drugs which eliminate or incapacitate illness leading unto regeneration & life.
It is becoming exceedingly obvious that LL has exactly what it takes to reduce cancer to only a diagnosis, to reduce HIV to a diagnosis. To possibly eliiminate NASH, just wait. (Wait for NAS to go to 0. Watch.) The extra ordinary powers this molecule possesses in its inordinate capacity & manner in which it binds to CCR5 will make it the lead drug in this revolutionary transitory process of conquering disease. This molecule will lead the charge and this company will orchestrate that revolution.
Although Leronlimab can stand alone in monotherapy, CytoDyn will take advantage of its friendly, harmonious nature and use it extensively in combination therapy since LL has no drug-drug interactions & no ASEs. CytoDyn shall become a conglomerate of symbiotic partnerships against a myriad of the worlds ailments, to make this revolution complete. BP will have no choice but to partner. Across the board, LL pan-partners with drugs that require its assistance to make it appear that they are actually functioning.
Later, once the Branded combination drug patent expires and it goes generic, the world will then realize that LL stand alone would of had the same beneficial effect. Regardless, given CytoDyn's current situation, this is how the revolutionary medicine transformation will be achieved.
Is there any wonder why Big Pharma wants this inevitable transition away from their expensive bandaids which only hide disease, permitting it to fester and demoralize towards meds like LL which eliminate and disable disease, which permit regeneration and life. Without the return of disease, there is no repeat income.
Ahead of us, It's an uphill battle, but day by day, we take a few steps higher. Some days we will go up by elevator.
CytoDynasty!
Should be an exciting month.
(9)
(0)Scroll down for more posts ▼
